ISSN: 0443-511
e-ISSN: 2448-5667
Usuario/a
Idioma
Herramientas del artículo
Envíe este artículo por correo electrónico (Inicie sesión)
Enviar un correo electrónico al autor/a (Inicie sesión)
Tamaño de fuente

Open Journal Systems

Distrofia muscular de cinturas y extremidades autosómica recesiva 10. Reporte de caso / Autosomal recessive limb-girdle muscular dystrophy-10. Case report

Alan Alberto Pérez-Arzola, Daniela Juárez-Melchor, Israel Enrique Crisanto-López, Aurea Vera-Loaiza, Yasmin Hernández-Castañeda, Tania Alejandra Guzmán-Santiago, Berenice Jiménez-Pérez, Pablo Omar Rodríguez-Hurtado, Wilbert Salazar-Bonilla

Resumen


Resumen

Introducción: la distrofia muscular de cinturas y extremidades autosómica recesiva 10 (LGMDR10) es una distrofia muscular causada por variantes patogénicas en el gen TTN que codifica la proteína titina, la cual es responsable de la flexibilidad y la tensión muscular. Su prevalencia es desconocida. Las principales manifestaciones clínicas son debilidad muscular proximal de predominio en la cintura escapular y pélvica, leve debilidad de músculos distales y atrofia muscular. El objetivo es presentar un reporte de caso de distrofia muscular de cinturas y extremidades autosómica recesiva 10 en un paciente mexicano.

Caso clínico: hombre de 39 años con hipotrofia de pierna izquierda, debilidad muscular de las 4 extremidades de predominio proximal y asimétrica, mialgias y calambres nocturnos. La creatinfosfoquinasa total fue de 819.7 UI/L, la velocidad de conducción nerviosa y la electromiografía presentó neuropatía femoral izquierda del tipo axonotmesis y neuropatía mixta axonal con patrón miopático de miembros superiores. El estudio molecular para distrofias musculares reportó 2 variantes patogénicas en estado heterocigoto compuesto en el gen TTN: c.107578C>T (p. Gln37860*) y c.104269C>T (p. Gln34767*), respectivamente.

Conclusiones: conforme a la información disponible, no existen casos reportados de LGMDR10 en México. Esta es una enfermedad progresiva con pérdida total de la deambulación entre la cuarta y la sexta década de vida, por lo que es importante su sospecha clínica para un diagnóstico oportuno, un asesoramiento adecuado y la prevención de complicaciones para una mejor calidad de vida.

 

Abstract

Background: The autosomal recessive limb-girdle muscular dystrophy-10 (LGMDR10) is a muscular dystrophy caused by pathogenetic variants in the TTN gene encoding the titin protein, which is responsible for muscle flexibility and tension. Its prevalence is unknown. The main clinical manifestations are proximal muscle weakness predominantly in the shoulder girdle and pelvic girdle, mild weakness of distal muscles and muscle atrophy. The objective is to present a case report of autosomal recessive limb-girdle muscular dystrophy-10 in a Mexican patient.

Clinical case: 39-year-old male with hypotrophy of the left leg, muscle weakness of the 4 limbs predominantly proximal and asymmetrical, myalgia and nocturnal cramps. Total creatine phosphokinase level was of 819.7 IU/L, nerve conduction velocity and electromyography with left femoral neuropathy of the axonotmesis type and mixed axonal neuropathy with myopathic pattern of upper limbs. The molecular study for muscular dystrophies reported 2 pathogenic variants in compound heterozygous state in the TTN gene: c.107578C>T (p. Gln37860*) and c.104269C>T (p. Gln34767*), respectively.

Conclusions: In line with the information available, there are no reported cases of LGMDR10 in Mexico. This is a progressive disease with total loss of ambulation between the fourth and the sixth decade of life, which is why its clinical suspicion is important for a timely diagnosis, an adequate counseling, and preventive measures of complications for a better quality of life.


Palabras clave


Conectina; Distrofias Musculares; Distrofia Muscular de Cinturas; Enfermedades Musculares; Debilidad Muscular / Connectin; Muscular Dystrophies; Muscular Dystrophies, Limb-Girdle; Muscular Diseases; Muscle Weakness

Texto completo:

PDF

Referencias


Udd B, Vihola A, Sarparanta J, et al. Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J. Neurology. 2005;64(4):636-42. doi: 10.1212/01.WNL.0000151853.50144.82

Rich KA, Moscarello T, Siskind C, et al. Novel heterozygous truncating titin variants affecting the A-band are associated with cardiomyopathy and myopathy/muscular dystrophy. Mol Genet Genomic Med. 2020;8(10):e1460. doi: 10.1002/mgg3.1460

Bouchard C, Tremblay JP. Limb–Girdle Muscular Dystrophies Classification and Therapies. J Clin Med. 2023;12(14):1-15. doi: 10.3390/jcm12144769

Chen Q, Zheng W, Xu H, et al. Digenic Variants in the TTN and TRAPPC11 Genes Co-segregating With a Limb-Girdle Muscular Dystrophy in a Han Chinese Family. Front Neurosci. 2021;15:601757. doi: 10.3389/fnins.2021.601757

Reyes L, Villamar P, Espinosa N. Distrofia muscular de cinturas 2J, revisión bibliográfica y reporte de un caso pediátrico en Ecuador. Metro Ciencia. 2020; 28(3):8-13. doi: 10.47464/MetroCiencia/vol28/3/2020/8-13

Georganopoulou DG, Moisiadis VG, Malik FA, et al. A Journey with LGMD: From Protein Abnormalities to Patient Impact. Protein J. 2021;40(4):466-88. doi: 10.1007/s10930-021-10006-9

Lombardo ME, Carraro E, Sancricca C, et al. UILDM (Italian Muscular Dystrophy Association) and Italian Consensus Conference Group on motor rehabilitation in muscular dystrophy. Management of motor rehabilitation in individuals with muscular dystrophies. 1st Consensus Conference report from UILDM - Italian Muscular Dystrophy Association (Rome, January 25-26, 2019). Acta Myol. 2021;40(2):72-87. doi: 10.36185/2532-1900-046

Morishima R, Schoser B. A Straightforward Approach to Analyze Skeletal Muscle MRI in Limb-Girdle Muscular Dystrophy for Differential Diagnosis: A Systematic Review. Muscles. 2023;2:374-388. doi: 10.3390/muscles2040029  

De Paepe B, Velghe E, Salminen L, et al. Diagnostic muscle biopsies in the era of genetics: the added value of myopathology in a selection of limb-girdle muscular dystrophy patients. Acta Neurol Belg. 2021;121(4):1019-33. doi: 10.1007/s13760-020-01559-0

Li C, Haller G, Weihl CC. Current and Future Approaches to Classify VUSs in LGMD-Related Genes. Genes (Basel). 2022;13(2):382. doi: 10.3390/genes13020382

Straub V, Murphy A, Udd B. 229th ENMC international workshop: Limb girdle muscular dystrophies – Nomenclature and reformed classification Naarden, the Netherlands, 2018;28(8):702-10. doi: 10.1016/j.nmd.2018.05.007

Savarese M, Vihola A, Oates EC, et al. Udd B. Genotype-phenotype correlations in recessive titinopathies. Genet Med. 2020;22(12):2029-40. doi: 10.1038/s41436-020-0914-2

Savarese M, Sarparanta J, Vihola A, et al. Increasing Role of Titin Mutations in Neuromuscular Disorders. J Neuromuscul Dis. 2016;3(3):293-308. doi: 10.3233/JND-160158

Misaka T, Yoshihisa A, Takeishi Y. Titin in muscular dystrophy and cardiomyopathy: Urinary titin as a novel marker. Clin Chim Acta. 2019;495:123-8. doi: 10.1016/j.cca.2019.04.005

Nigro V, Savarese M. Genetic basis of limb-girdle muscular dystrophies: The 2014 update. Acta Myol. 2014;33(1):1-12.

Leońska-Duniec A, Borczyk M, Piechota M, et al. TTN Variants Are Associated with Physical Performance and Provide Potential Markers for Sport-Related Phenotypes. Int J Environ Res Public Health. 2022;19(16):10173. doi: 10.3390/ijerph191610173

Chen Q, Zheng W, Xu H, et al. Digenic Variants in the TTN and TRAPPC11 Genes Co-segregating With a Limb-Girdle Muscular Dystrophy in a Han Chinese Family. Front Neurosci. 2021;15:601757. doi: 10.3389/fnins.2021.601757

Loescher CM, Hobbach AJ, Linke WA. Titin (TTN): from molecule to modifications, mechanics, and medical significance. Cardiovasc Res. 2022;118(14):2903-18. doi: 10.1093/cvr/cvab328

Jolfayi AG, Kohansal E, Ghasemi S, et al. Exploring TTN variants as genetic insights into cardiomyopathy pathogenesis and potential emerging clues to molecular mechanisms in cardiomyopathies. Sci Rep. 2024;14(1):5313. doi: 10.1038/s41598-024-56154-7

Wang G, Lv X, Xu L, et al. Novel compound heterozygous mutations in the TTN gene: elongation and truncation variants causing limb-girdle muscular dystrophy type 2J in a Han Chinese family. Neurol Sci. 2022;43(5):3427-33. doi: 10.1007/s10072-022-05979-z

Rees M, Nikoopour R, Fukuzawa A, et al. Making sense of missense variants in TTN-related congenital myopathies. Acta Neuropathol. 2021;141(3):431-53. doi: 10.1007/s00401-020-02257-0

Pénisson-Besnier I, Hackman P, Suominen T, et al. Myopathies caused by homozygous titin mutations: Limb-girdle muscular dystrophy 2J and variations of phenotype. J Neurol Neurosurg Psychiatry. 2010;81(11):1200-2.

Khan A, Wang R, Han S, et al. Homozygous missense variant in the TTN gene causing autosomal recessive limb-girdle muscular dystrophy type 10. BMC Med Genet. 2019;20(1):166. doi: 10.1186/s12881-019-0895-7

Pozsgai E, Griffin D, Potter R,  et al. Unmet needs and evolving treatment for limb girdle muscular dystrophies. Neurodegener Dis Manag. 2021;11(5):411-29. doi: 10.2217/nmt-2020-0066




DOI: https://doi.org/10.24875/10.5281/zenodo.14201220

Enlaces refback

  • No hay ningún enlace refback.